Feed HROW
HR
Harrow Health, Inc.
HROW · NASDAQ
$43.71 -0.66% (-$0.29)
1M +10.00%
Market Cap $1.6B
P/E Ratio -
Div. Yield -
ROE 33.79%
Bulios Fair Price
$108.63
148.5% upside
Current Price
$43.71
Undervalued Fair Value Overvalued
Valuation
2 /100
Expensive EV/EBITDA 86.91x
P/FCF 36.86x
P/S 6.06x
Growth
100 /100
Growing Rev. growth 45.39%
Book val. growth 23.87%
EPS growth N/A
Profitability
43 /100
Moderate Gross margin 74.11%
FCF margin 16.45%
Net margin 0.00%
Quality
7 /100
Poor ROIC 4.77%
Asset turnover 0.64x
ROE 0.00%
Debt
18 /100
High Debt/Equity 10.61x
Net debt/EBITDA 9.76x
Current ratio 2.48x
Stability
23 /100
Unstable Beta 0.26x
Profitable years 0
Rev. volatility 8.54%
Ask StockBot about HROW
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mark L. Baum
Employees
373
Headquarters
Nashville
Upcoming events
10 AUG
Earnings
Upcoming earnings report